Unlocking the Versatile Potential: Adipose-Derived Mesenchymal Stem Cells in Ocular Surface Reconstruction and Oculoplastics
February 2024
in “
World journal of stem cells
”
adipose-derived mesenchymal stem cells MSCs regenerative properties immunomodulatory properties ocular surface reconstruction oculoplastics inflammation reduction wound healing tissue integration dry eye syndrome corneal injuries limbal stem cell deficiency fat-derived stem cells stem cells eye surface reconstruction eye plastic surgery reduce inflammation heal wounds integrate tissue dry eyes cornea injuries limbal deficiency
Studysummary This review highlights the potential of adipose-derived mesenchymal stem cells as a cost-effective solution for tissue restoration and regeneration in ophthalmic and oculoplastic surgeries, addressing unmet needs in reconstructive procedures.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
Adipose-derived mesenchymal stem cells (MSCs) show significant promise in ocular surface reconstruction and oculoplastics due to their regenerative and immunomodulatory properties. They are abundant, cost-effective, and relatively safe, making them ideal for clinical applications. MSCs have demonstrated efficacy in reducing inflammation, promoting wound healing, and improving tissue integration in conditions like dry eye syndrome, corneal injuries, and limbal stem cell deficiency. However, further research is needed to standardize clinical procedures, ensure long-term safety, and address ethical and regulatory considerations before MSCs can become standard treatments in ocular medicine.
